Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$935M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$606M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$598M |
| 4 |
Alibaba
BABA
|
+$340M |
| 5 |
SPDR Gold Trust
GLD
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$47.4M |
| 2 |
Linde
LIN
|
+$29.9M |
| 3 |
Walmart Inc
WMT
|
+$28.5M |
| 4 |
Microsoft
MSFT
|
+$28.4M |
| 5 |
Deere & Co
DE
|
+$26.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 24.27% |
| 2 | Consumer Discretionary | 16.92% |
| 3 | Healthcare | 15.14% |
| 4 | Financials | 5.73% |
| 5 | Industrials | 3.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Medifast
MED
$141M
| $3.92M | 0.02% |
20,376
-594
| -3% | -$146K |
|
327
Zions Bancorporation
ZION
$10.3B
| $3.87M | 0.02% |
62,506
+6,483
| +12% | +$356K |
|
328
American Well
AMWL
$230M
| $3.85M | 0.02% |
21,119
-516
| -2% | -$112K |
|
|
THS
329
DELISTED
Treehouse Foods
THS
| $3.85M | 0.02% |
96,414
+7,144
| +8% | +$292K |
|
|
MRSH
330
Marsh
MRSH
$91.5B
| $3.84M | 0.02% |
25,369
+23,802
| +1,519% | +$3.6M |
|
|
IRBT
331
DELISTED
iRobot
IRBT
| $3.83M | 0.02% |
48,808
-1,635
| -3% | -$139K |
|
332
Canadian Natural Resources
CNQ
$93.8B
| $3.77M | 0.02% |
210,702
+149,648
| +245% | +$2.46M |
|
333
Lockheed Martin
LMT
$136B
| $3.77M | 0.02% |
+10,924
| New | +$3.95M |
|
|
NVRO
334
DELISTED
NEVRO CORP.
NVRO
| $3.76M | 0.02% |
32,334
-2,439
| -7% | -$319K |
|
|
NARI
335
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $3.75M | 0.02% |
46,261
-3,688
| -7% | -$310K |
|
336
Merit Medical Systems
MMSI
$5.32B
| $3.75M | 0.02% |
52,222
-4,484
| -8% | -$304K |
|
|
MOMO
337
Hello Group
MOMO
$866M
| $3.7M | 0.02% |
349,411
+140,105
| +67% | +$1.76M |
|
|
B
338
Barrick Mining
B
$73.2B
| $3.68M | 0.02% |
204,008
-7,355
| -3% | -$148K |
|
339
Suncor Energy
SU
$70.3B
| $3.64M | 0.02% |
+175,517
| New | +$3.51M |
|
340
Beyond Meat
BYND
$277M
| $3.61M | 0.02% |
34,269
-1,317
| -4% | -$161K |
|
341
Equinix
EQIX
$103B
| $3.58M | 0.02% |
4,532
+155
| +4% | +$129K |
|
342
Norfolk Southern
NSC
$75.1B
| $3.58M | 0.02% |
14,966
+450
| +3% | +$115K |
|
343
Biogen
BIIB
$30.7B
| $3.57M | 0.02% |
12,622
-5,234
| -29% | -$1.72M |
|
344
Jefferies Financial Group
JEF
$13.1B
| $3.56M | 0.02% |
100,254
+24,811
| +33% | +$830K |
|
345
Ares Capital
ARCC
$14.4B
| $3.52M | 0.02% |
173,358
+26,219
| +18% | +$525K |
|
346
First Horizon
FHN
$12.1B
| $3.5M | 0.02% |
214,673
+42,768
| +25% | +$681K |
|
347
Nu Skin
NUS
$267M
| $3.49M | 0.02% |
86,156
+2,277
| +3% | +$115K |
|
348
SEI Investments
SEIC
$12.6B
| $3.46M | 0.02% |
58,382
-1,382
| -2% | -$84.3K |
|
349
Telus
TU
$15.3B
| $3.44M | 0.02% |
156,407
+30,334
| +24% | +$684K |
|
|
ONEM
350
DELISTED
1Life Healthcare
ONEM
| $3.41M | 0.02% |
168,430
+30,626
| +22% | +$787K |
|
Similar funds
Ray Dalio's Q3 2021 Portfolio in Review
As of Q3 2021, Ray Dalio held 821 positions worth $18.3B, up 17% from $15.6B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Ray Dalio deployed $3.42B of net new capital in Q3 2021, opening 117 new positions and adding to 343 existing holdings. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 8,990,211 shares worth $70M.
By sector, the portfolio is most concentrated in Consumer Staples at 24% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Danaher, an estimated $47.4M trimmed.
- Ray Dalio's largest Q3 2021 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 8,990,211 shares worth $70M.
- Ray Dalio added most to iShares MSCI Emerging Markets ETF in Q3 2021, an estimated $935M increase.
- Ray Dalio's biggest Q3 2021 reduction was Danaher, cutting an estimated $47.4M.
- Ray Dalio fully exited Linde in Q3 2021, selling an estimated $29.9M.
- Ray Dalio's ten largest holdings make up 38% of its $18.3B portfolio in Q3 2021.
- Ray Dalio opened 117 new positions and closed 138 in Q3 2021.
- Ray Dalio's portfolio value rose 17% quarter-over-quarter to $18.3B.
Based on Bridgewater Associates's 13F filing for Q3 2021, filed 12 Nov 2021.